(Q52935015)

9 May 2018

title

Modulation of lymphocyte phenotype and function by immunoglobulins. (English)

1 reference

9 May 2018

author name string

Kirschbaum J

1

1 reference

9 May 2018

Forschner K

2

1 reference

9 May 2018

Rasche C

3

1 reference

9 May 2018

Worm M

4

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 February 2006

1 reference

9 May 2018

British Journal of Dermatology

published in

1 reference

9 May 2018

volume

154

1 reference

9 May 2018

issue

2

1 reference

9 May 2018

page(s)

225-230

1 reference

9 May 2018

Update on glucocorticoid action and resistance

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

Dermatological uses of high-dose intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

Negative feedback regulation of IgE synthesis by murine CD23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

CD21 is a ligand for CD23 and regulates IgE production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

IVIG--mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

Cytotoxic T cells specifically induce Fas on target cells, thereby facilitating exocytosis-independent induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

Expression and functional role of co-stimulatory molecules in CD40+IL-4-stimulated B cells from atopic and non-atopic donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

The role of immunoglobulin therapy in allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

The same tyrosine-based inhibition motif, in the intra-cytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.07005.X

10.1111/J.1365-2133.2005.07005.X

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018